• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丁苯那嗪可引发急性肌张力障碍反应。

Tetrabenazine induces acute dystonic reactions.

作者信息

Burke R E, Reches A, Traub M M, Ilson J, Swash M, Fahn S

出版信息

Ann Neurol. 1985 Feb;17(2):200-2. doi: 10.1002/ana.410170217.

DOI:10.1002/ana.410170217
PMID:3977303
Abstract

Four patients suffered acute dystonic reactions caused by tetrabenazine. Because dystonic reactions have previously been reported only after dopamine receptor blockade and not with dopamine depletion, it is likely that the ability of tetrabenazine to induce acute dystonia is due to its dopamine receptor blocking properties. Because tetrabenazine can induce acute dystonia even when combined with alpha-methyl-p-tyrosine, presynaptic dopamine stores may not be necessary for these reactions to occur.

摘要

4名患者出现了由丁苯那嗪引起的急性肌张力障碍反应。由于此前仅在多巴胺受体阻断后而非多巴胺耗竭后报道过肌张力障碍反应,因此丁苯那嗪诱发急性肌张力障碍的能力可能归因于其多巴胺受体阻断特性。因为即使与α-甲基-对-酪氨酸联合使用,丁苯那嗪仍可诱发急性肌张力障碍,所以这些反应的发生可能不需要突触前多巴胺储备。

相似文献

1
Tetrabenazine induces acute dystonic reactions.丁苯那嗪可引发急性肌张力障碍反应。
Ann Neurol. 1985 Feb;17(2):200-2. doi: 10.1002/ana.410170217.
2
Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs.尽管停用了多巴胺受体阻断药物,但仍出现复发性急性肌张力障碍反应和动眼危象。
Mov Disord. 2009 Jun 15;24(8):1226-9. doi: 10.1002/mds.22532.
3
[Drug-induced dystonia misinterpreted as hysteria].
Tidsskr Nor Laegeforen. 1996 Mar 10;116(7):844-5.
4
Acute dystonic reaction to metoclopramide in patients carrying homozygous cytochrome P450 2D6 genetic polymorphisms.携带纯合细胞色素P450 2D6基因多态性的患者对甲氧氯普胺的急性肌张力障碍反应。
Neth J Med. 2006 May;64(5):160-2.
5
Albendazole-induced dystonic reaction: a case report.阿苯达唑诱发的张力障碍反应:一例报告
Turk J Pediatr. 2011 Nov-Dec;53(6):709-10.
6
Acute dystonic reaction associated with foscarnet administration.与膦甲酸钠给药相关的急性肌张力障碍反应。
Am J Ther. 2008 Mar-Apr;15(2):184-6. doi: 10.1097/MJT.0b013e31815afe5b.
7
Anticholinergic prophylaxis of acute haloperidol-induced acute dystonic reactions.抗胆碱能药物预防急性氟哌啶醇诱发的急性肌张力障碍反应。
J Clin Psychopharmacol. 1987 Jun;7(3):164-6.
8
High vulnerability to acute dystonic reactions: a case of antipsychotic exposure and uncontrolled seizure activity.
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun;29(5):770-4. doi: 10.1016/j.pnpbp.2005.04.005.
9
Tetrabenazine-induced oculogyric crisis - a rare complication in the treatment of Gilles de la Tourette syndrome.丁苯那嗪诱发的动眼危象——一种治疗抽动秽语综合征时罕见的并发症。
Neuropsychiatr Dis Treat. 2016 Feb 25;12:497-9. doi: 10.2147/NDT.S98694. eCollection 2016.
10
[Acute dystonia].[急性肌张力障碍]
Ned Tijdschr Geneeskd. 1997 Jul 26;141(30):1471-4.

引用本文的文献

1
Real-World Experiences with VMAT2 Inhibitors in Pediatric Hyperkinetic Movement Disorders.小儿多动性运动障碍中VMAT2抑制剂的真实世界经验
Tremor Other Hyperkinet Mov (N Y). 2025 Jun 16;15:26. doi: 10.5334/tohm.1023. eCollection 2025.
2
The epidemiology and phenomenology of non-antipsychotic-induced dystonia: a hybrid systematic-narrative review.非抗精神病药物所致肌张力障碍的流行病学与现象学:一项系统-叙述性混合综述
Eur Psychiatry. 2025 Feb 10;68(1):e36. doi: 10.1192/j.eurpsy.2025.18.
3
Meta-analysis and systematic review of vesicular monoamine transporter (VMAT-2) inhibitors in schizophrenia and psychosis.
精神分裂症和精神病中囊泡单胺转运体(VMAT-2)抑制剂的荟萃分析和系统评价。
Psychopharmacology (Berl). 2024 Feb;241(2):225-241. doi: 10.1007/s00213-023-06488-3. Epub 2024 Jan 19.
4
Deutetrabenazine in Tics Associated with Tourette Syndrome.氘代丁苯那嗪治疗与妥瑞氏综合征相关的抽动
Tremor Other Hyperkinet Mov (N Y). 2016 Nov 7;6:422. doi: 10.7916/D8M32W3H. eCollection 2016.
5
Tetrabenazine-induced oculogyric crisis - a rare complication in the treatment of Gilles de la Tourette syndrome.丁苯那嗪诱发的动眼危象——一种治疗抽动秽语综合征时罕见的并发症。
Neuropsychiatr Dis Treat. 2016 Feb 25;12:497-9. doi: 10.2147/NDT.S98694. eCollection 2016.
6
Rapid improvement of tardive dyskinesia with tetrabenazine, clonazepam and clozapine combined: a naturalistic long-term follow-up study.经四苯嗪、氯硝西泮和氯氮平联合治疗迟发性运动障碍的快速改善:一项自然长期随访研究。
J Neurol. 2012 Apr;259(4):660-4. doi: 10.1007/s00415-011-6235-2. Epub 2011 Nov 9.
7
Management of Huntington's disease: role of tetrabenazine.亨廷顿病的治疗:四苯丁嗪的作用。
Ther Clin Risk Manag. 2011;7:123-9. doi: 10.2147/TCRM.S17152. Epub 2011 Mar 21.
8
Antipsychotic-induced movement disorders: evaluation and treatment.抗精神病药物所致运动障碍:评估与治疗
Psychiatry (Edgmont). 2005 Mar;2(3):36-41.
9
Tetrabenazine (Xenazine), An FDA-Approved Treatment Option For Huntington's Disease-Related Chorea.丁苯那嗪(Xenazine),一种获美国食品药品监督管理局批准用于治疗亨廷顿舞蹈症相关舞蹈症的治疗选择。
P T. 2008 Dec;33(12):690-4.
10
Movement disorder emergencies.运动障碍急症
J Neurol. 2008 Aug;255 Suppl 4:2-13. doi: 10.1007/s00415-008-4002-9.